MKT Capital Completes Successful Withhold Campaign at Aurinia Pharmaceuticals
Following a successful withhold campaign by Olshan client MKT Capital, two directors of Aurinia Pharmaceuticals – the Chairman of the Board and the Chairman of the Compensation Committee – tendered their resignations after failing to receive the requisite majority vote. Shareholders also overwhelmingly voted down Aurinia’s say-on-pay proposal and an amendment to its equity incentive plan. MKT Capital launched its withhold campaign in an effort to combat egregious executive compensation practices and instill a sense of accountability in Aurinia’s boardroom. Vice Chair of Olshan’s Shareholder Activism Practice Group Ryan Nebel represented MKT Capital in its campaign.
Attorneys
Capabilities
Media Contact
Marketing Contact
Mizi Mehaj
Marketing & Administrative Manager
mmehaj@olshanlaw.com
212.451.2319